Pradaxa gives clinicians a new tool for preventing strokes and
blood clots in patients with atrial fibrillation. Learn how it works,
who’s eligible to receive it, and how to administer it.
anticoagulants
AHA releases new guidelines for reversing non–vitamin K oral anticoagulants
The American Heart Association (AHA) has released a scientific statement on reversing the effects of non–vitamin K oral anticoagulants. Read…
Pharmacology review: Drugs that alter blood coagulation
Brush up on your knowledge of these potentially life-saving drugs.
What’s new in anticoagulation for patients with atrial fibrillation?
Mrs. Muriel H, age 78, is admitted to the medical-surgical unit with GI bleeding. She has a 5-year history of…
